Alliqua BioMedical Inc (ALQA)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Alliqua BioMedical Inc (ALQA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011879
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Alliqua BioMedical Inc (Alliqua BioMedical), formerly HepaLife Technologies Inc is a regenerative technology company that builds a suite of regenerative solutions for wound and tissue repair. The company’s product categories include ultrasound healing therapy, human biologics, antimicrobial protection, and hydration. Its contract manufacturing business unit provides custom hydrogels to the OEM market. Alliqua BioMedical develops and manufactures electron-beam cross-linked sheet gels for manufacturer of medical devices, cosmeceuticals, and other commercial product applications. The company’s customer service professionals assist with order placement, product training, and reimbursement. Alliqua BioMedical is headquartered in Yardley, Pennsylvania, the US.

Alliqua BioMedical Inc (ALQA) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Alliqua BioMedical Inc, Medical Devices Deals, 2011 to YTD 2017 9
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Alliqua Enters Into Distribution Agreement With Sorbion 11
Licensing Agreements 12
Alliqua BioMedical Amends Licensing Agreement with Celgene Cellular Therapeutics 12
Alliqua BioMedical Amends Licensing Agreement with Celgene Cellular Therapeutics 13
Alliqua Enters Into Licensing Agreement With Noble Biomaterials 14
Alliqua Enters Into Licensing Agreement With Celgene Cellular Therapeutics For Wound Care Products 15
Equity Offering 16
Alliqua BioMedical Raises USD2.8 Million in Private Placement of Shares 16
Alliqua Completes Private Placement Of Shares For US$15 Million 17
Alliqua Completes Private Placement Of Shares For US$5.3 Million Upon Exercise Of Warrants 18
Alliqua Completes Private Placement Of Shares For US$0.4 Million 19
Alliqua BioMedical Inc – Key Competitors 20
Alliqua BioMedical Inc – Key Employees 21
Alliqua BioMedical Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Aug 10, 2017: Alliqua BioMedical Reports Second Quarter of Fiscal Year 2017 Financial Results 23
May 09, 2017: Alliqua BioMedical Reports First Quarter of Fiscal Year 2017 Financial Results 26
Apr 06, 2017: Alliqua BioMedical Announces Preliminary First Quarter Fiscal 2017 Revenue and Updates Fiscal Year 2017 Outlook 27
Mar 07, 2017: Alliqua BioMedical Reports Fourth Quarter and Fiscal Year 2016 Financial Results 28
Nov 04, 2016: Alliqua BioMedical Reports Third Quarter and Nine-Months Fiscal Year 2016 Financial Results 31
Oct 05, 2016: Alliqua BioMedical Announces Preliminary Third Quarter of Fiscal Year 2016 Revenue 33
Oct 05, 2016: Alliqua BioMedical Announces Preliminary Third Quarter of Fiscal Year 2016 Revenue; Earnings Conference Call Scheduled for November 4th 34
Aug 09, 2016: Alliqua BioMedical Reports Second Quarter and Six Months Fiscal Year 2016 Financial Results 35
Jul 07, 2016: Alliqua BioMedical Announces Preliminary Second Quarter of Fiscal Year 2016 Revenue 37
May 10, 2016: Alliqua BioMedical Reports First Quarter Financial Results 38
Feb 23, 2016: Alliqua BioMedical Reports Fourth Quarter and Fiscal Year 2015 Financial Results 40
Corporate Communications 42
Feb 19, 2016: Alliqua BioMedical Announces Changes to Its Board of Directors 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Alliqua BioMedical Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Alliqua BioMedical Inc, Medical Devices Deals, 2011 to YTD 2017 9
Alliqua BioMedical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Alliqua Enters Into Distribution Agreement With Sorbion 11
Alliqua BioMedical Amends Licensing Agreement with Celgene Cellular Therapeutics 12
Alliqua BioMedical Amends Licensing Agreement with Celgene Cellular Therapeutics 13
Alliqua Enters Into Licensing Agreement With Noble Biomaterials 14
Alliqua Enters Into Licensing Agreement With Celgene Cellular Therapeutics For Wound Care Products 15
Alliqua BioMedical Raises USD2.8 Million in Private Placement of Shares 16
Alliqua Completes Private Placement Of Shares For US$15 Million 17
Alliqua Completes Private Placement Of Shares For US$5.3 Million Upon Exercise Of Warrants 18
Alliqua Completes Private Placement Of Shares For US$0.4 Million 19
Alliqua BioMedical Inc, Key Competitors 20
Alliqua BioMedical Inc, Key Employees 21
Alliqua BioMedical Inc, Subsidiaries 22

★海外企業調査レポート[Alliqua BioMedical Inc (ALQA)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Campanile UK Ltd:企業の戦略・SWOT・財務分析
    Campanile UK Ltd - Strategy, SWOT and Corporate Finance Report Summary Campanile UK Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Kuala Lumpur Kepong Berhad (KLK):企業の財務・戦略的SWOT分析
    Kuala Lumpur Kepong Berhad (KLK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • JSP Corp (7942):企業の財務・戦略的SWOT分析
    JSP Corp (7942) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Titan Logix Corp (TLA):企業の財務・戦略的SWOT分析
    Summary Titan Logix Corp (Titan) is a technology company that offers research and development, manufacturing and marketing of advanced technology fluid management solutions. The company's products include stationary guided wave radar gauges for level measurement and overfill prevention, for use in t …
  • Xylem Inc (XYL):電力:M&Aディール及び事業提携情報
    Summary Xylem Inc (Xylem) is a water technology company. It designs, manufactures, and services engineered solutions ranging across a wide variety of applications. The company’s offerings address customer needs across the water cycle, from the delivery, measurement and use of drinking water to the c …
  • Covance Inc:企業の戦略的SWOT分析
    Covance Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Statkraft AS:企業の戦略・SWOT・財務分析
    Statkraft AS - Strategy, SWOT and Corporate Finance Report Summary Statkraft AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Save The Children Federation Inc:企業の戦略的SWOT分析
    Save The Children Federation Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Uzma Bhd (UZMA):企業の財務・戦略的SWOT分析
    Summary Uzma Bhd (Uzma) is an oil and gas service and equipment company. The company provides integrated solutions to the upstream sector. It offers geoscience and petroleum engineering, laboratory solutions, drilling and well services, production operation and optimization, manpower consultancy and …
  • Pets at Home Group Plc:戦略・SWOT・企業財務分析
    Pets at Home Group Plc - Strategy, SWOT and Corporate Finance Report Summary Pets at Home Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Bausch Health Companies Inc (VRX):医療機器:M&Aディール及び事業提携情報
    Summary Bausch Health Companies Inc(Bausch Health) formerly known as Valeant Pharmaceuticals International Inc, develops, manufactures and markets several branded, over-the-counter (OTC) and generic drugs. The company also offers medical devices such as medical contact lenses, intraocular lenses, op …
  • Pegasystems Inc (PEGA):企業の財務・戦略的SWOT分析
    Pegasystems Inc (PEGA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Ecclesiastical Insurance Group plc:企業の戦略・SWOT・財務情報
    Ecclesiastical Insurance Group plc - Strategy, SWOT and Corporate Finance Report Summary Ecclesiastical Insurance Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Youlchon Chemical Co Ltd:企業の戦略・SWOT・財務情報
    Youlchon Chemical Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Youlchon Chemical Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • P. H. Glatfelter Company (GLT):企業の財務・戦略的SWOT分析
    P. H. Glatfelter Company (GLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Ambu AS (AMBU B):企業の財務・戦略的SWOT分析
    Ambu AS (AMBU B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • BPER Banca Spa:企業のM&A・事業提携・投資動向
    BPER Banca Spa - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BPER Banca Spa Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • E-CO Energi Holding AS:企業の戦略的SWOT分析
    E-CO Energi Holding AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • de Volksbank NV:企業の戦略・SWOT・財務情報
    de Volksbank NV - Strategy, SWOT and Corporate Finance Report Summary de Volksbank NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Laboratoires Thea SA-製薬・医療分野:企業M&A・提携分析
    Summary Laboratoires Thea SA (Thea) is an independent pharmaceutical company that researches, develops, manufactures, and commercializes a range of eye care products. The company’s products find application in the diagnosis, surgery and treatment of ophthalmic diseases such as dry eye, allergies, gl …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆